Bruce J. Averbook

Combined Analysis of Phase III Trials Evaluating [99mTc]Tilmanocept and Vital Blue Dye for Identification of Sentinel Lymph Nodes in Clinically Node-Negative Cutaneous Melanoma

Vernon K. Sondak, Dennis W. King, Jonathan S. Zager et al. · Annals of Surgical Oncology · 2012 · 145 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

RANTES Secretion by Gene-Modified Tumor Cells Results in Loss of Tumorigenicity <i>In Vivo:</i> Role of Immune Cell Subpopulations

James J. Mulé, Mary Custer, Bruce J. Averbook et al. · Human Gene Therapy · 1996 · 135 citations · Full text

Life Sciences, Immunology, Oncology +17

Divergent effects of 4-1BB antibodies on antitumor immunity and on tumor-reactive T-cell generation.

Julian A. Kim, Bruce J. Averbook, Karen Chambers et al. · PubMed · 2001 · 91 citations

Medicine, Immunology, Oncology +17

Factors Predictive of the Status of Sentinel Lymph Nodes in Melanoma Patients from a Large Multicenter Database

Richard L. White, Gregory D. Ayers, Virginia H. Stell et al. · Annals of Surgical Oncology · 2011 · 89 citations

Medicine, Oncology, Surgery +17

Pediatric melanoma: Analysis of an international registry

Bruce J. Averbook, Sandra J. Lee, Keith A. Delman et al. · Cancer · 2013 · 86 citations · Full text

Medicine, Pediatrics, Metastasis +4